AT002 (CBAS-173, EJ212/007-Cl2-5) is a recombinant human IgG1 monoclonal antibody. AT002 targets the cell surface protein activated leukocyte adhesion molecule (ALCAM) /CD166. AT002 can be used in the research of cancer, autoimmune diseases and inflammatory diseases.
